Rebetol schering

Common Questions and Answers about Rebetol schering

rebetol

Avatar n tn My treatment nurse set me up on the program with Pegassist (Genentech Pegasys system): 1-888-941-3331 Peginterferon and Ribaviron Commitment to Care (Merck PEG-Intron system): 1-866-363-6379, opt 1 Hope that helps.
Avatar f tn not sure there is much of a difference but i have heard pegasys has less side effects.
Avatar f tn Pegasys (peginterferon alfa-2a) and Copegus (ribavirin) which is Roche and Pegintron (peginterferon alfa-2b) and Rebetol (ribavirin) which is Schering-Plough. Both are considered the current SOC.
Avatar m tn SGP) reported that results from a planned interim analysis of an ongoing Phase II study of boceprevir, its investigational oral hepatitis C protease inhibitor, in 595 treatment-naive patients with chronic hepatitis C virus (HCV) genotype 1 were presented at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL). The ongoing study evaluates boceprevir in 28-week and 48-week treatment regimens.
Avatar n tn Schering-Plough (Rebetol): $11.03/capsule (AWP) = $22,236.48 for 48 weeks Roche (Copegus): $6.33/capsule (AWP as of 9/03; $5.58/capsule WAC) = $12,761.
Avatar m tn KENILWORTH, N.J., November 24, 2008 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today provided a clinical update on boceprevir, its lead investigational oral hepatitis C protease inhibitor currently in Phase III development. The company believes boceprevir has the potential to be a first-in-class and best-in-class protease inhibitor for treating chronic hepatitis C.
158241 tn?1237719523 The two randomized, double-blind, placebo-controlled studies will evaluate the efficacy of boceprevir in combination with PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) compared to standard of care with PEGINTRON and REBETOL alone. The Company said the two pivotal studies will run concurrently and are projected to enroll a total of more than 1,400 patients at U.S. and international sites. Comment drofi: The study designs seem to be professional.
Avatar m tn SGP) today reported that a planned interim analysis of a Phase II study showed that boceprevir, its investigational oral hepatitis C protease inhibitor, in combination with peginterferon and ribavirin markedly increased sustained virologic response (SVR) rates with 28 weeks of therapy and nearly doubled SVR with 48 weeks of therapy compared to current standard of care, peginterferon and ribavirin (control group) for 48 weeks.
Avatar m tn From Schering-Ploughs PEG-Intron prescribing info: http://www.spfiles.com/pipeg-intron.pdf “Effect of food on absorption of ribavirin: Both AUC and C-MAX increased by seventy percent when Rebetol Capsules were administered with a high fat meal: (841 kcal, 53.8 g fat, 31.6 g protein, and 57.4 g carbohydrate) in a single-dose pharmacokinetic study.
1253246 tn?1332073310 http://www.spfiles.com/pipeg-intron.pdf Effect of food on absorption of ribavirin: Both AUC and C-MAX increased by seventy percent when Rebetol Capsules were administered with a high fat meal: (841 kcal, 53.8 g fat, 31.6 g protein, and 57.4 g carbohydrate) in a single-dose pharmacokinetic study.
Avatar m tn 1-800-521-7157 -The manufacturers of PegIntron plus Rebetol have the Commitment to Care program. • Vertex: 855-837-8394 - The manufacturer of the recently approved Hepatitis C drug Incivek, has the Vertex Free Medicine Program. This program will provide telaprevir (Incivek) at no cost to people who do not have insurance, are not covered by other benefits programs, and have an annual household income of $100,000 or less.
Avatar m tn I'm taking Rebetol (Schering Plough). I'm UND since week 4, maybe earlier. No change of brand/manufacturer during tx. I'm in week 40.
Avatar m tn I started my treatment for my Hep C genotype 1A at June 2007 for 52 weeks with Pegylated Interferon 2A 100 Mg weekly & 800 Mg Ribavirin daily. I used Schering-plough product (PegIntron & Rebetol). My HCV RNA result before treatment was 1,700,000 copy. After 52 weeks I found that the treatment was sucsses with my last HCV RNA result "no detection" (Sept 2008). But just about 2 months ago at Jan 2009 I got my SGOT, SGPT & GGT increase again.
Avatar n tn I am participating in a study so the drugs are free, but my insurance will cover them with a copay. I believe that one of the manufacturers, Schering Plough, supports a program of drug distribution for people who can prove they are under- or non-insured. Look at their website for more info.
686697 tn?1229530856 , November 24, 2008 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today provided a clinical update on boceprevir, its lead investigational oral hepatitis C protease inhibitor currently in Phase III development. The company believes boceprevir has the potential to be a first-in-class and best-in-class protease inhibitor for treating chronic hepatitis C.
Avatar f tn 1-800-521-7157 -The manufacturers of PegIntron plus Rebetol have the Commitment to Care program. • Vertex: 855-837-8394 - The manufacturer of the recently approved Hepatitis C drug Incivek, has the Vertex Free Medicine Program. This program will provide telaprevir (Incivek) at no cost to people who do not have insurance, are not covered by other benefits programs, and have an annual household income of $100,000 or less.
Avatar m tn SGP) today announced that the European Commission has approved revised dosing instructions allowing for a shorter, 24-week course of PEGINTRON® (1.
Avatar f tn That said you need to check out your Rebetol dose. Something is strange with your dosing. Generally, 800 mg Rebetol is the lowest dose given, while 150 mcg PegIntron is the highest. May I ask how much you weigh? Are you genotype 1? An easy way to look at if you are getting the correct weight based doses is to do these calculations: 1. Calculate your weight in kilos (your weight in lbs divided by 2.2). 2. Divide your ribavarin dose by your weight in kilos.
Avatar m tn Schering-Plough Corporation (NYSE: SGP) provided an update on the clinical development program for boceprevir, its investigational oral hepatitis C protease inhibitor.
443006 tn?1229201842 Rebetol is Schering-Plough's brand name for the Ribavirin. I am on 800mg per day and on Pegasys (PEGinterferon by Roche) 180mcg per week.
439539 tn?1233465815 I checked Schering-Ploughs prescribing information/product information, and there is a table nr. 6 which actually indicates 64 mcg PegIntron for a weight between 40 and 50 kg. This is confusing since they also state that PegIntron should be dosed at 1.5 mcg per kilo. So this is probably where your dosage comes from, although it says that 800 mg ribavirin (Rebetol) is enough for your weight. I would be reluctant though to take less than 1.5 mcg PegIntron per kilo, but that is me.
Avatar m tn Among subjects with detectable HCV-RNA at TW8 who had attained undetectable HCV-RNA at TW24 and completed at least 28 weeks of treatment, the SVR rates were 66% (45/68) in VICTRELIS-RGT arm (4 weeks of PegIntron and REBETOL then 24 weeks of VICTRELIS with PegIntron and REBETOL followed by 20 weeks of PegIntron and REBETOL alone) and 75% (55/73) in VICTRELIS-PR48 arms (4 weeks of PegIntron and REBETOL then 44 weeks of VICTRELIS with PegIntron and REBETOL).
Avatar f tn Article Controls But on a conference call on Monday Merck and Schering-Plough executives said they are structuring the deal so that Schering-Plough will change its name to Merck and absorb its larger partner. The reason: to avoid triggering a change-in-control clause in a deal between Schering and Johnson & Johnson (nyse: JNJ - news - people ).